literatur.social

IndieAuthors.Social NewsSpringer Nature Says It Has Reached 50 Percent Open AccessFrank Vrancken Peeters at Springer Nature goes over key points of progress behind a key milestone for the scholarly publisher. <a href="https://publishingperspectives.com/2025/04/springer-nature-says-it-has-reached-50-percent-open-access/" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://publishingperspectives.com/2025/04/springer-nature-says-it-has-reached-50-percent-open-access/</a><a href="https://indieauthors.social/tags/AcademicPublishing" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#AcademicPublishing</a> <a href="https://indieauthors.social/tags/OpenAccess" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#OpenAccess</a> <a href="https://indieauthors.social/tags/PublishingResearch" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#PublishingResearch</a> <a href="https://indieauthors.social/tags/ScholarlyPublishing" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ScholarlyPublishing</a> <a href="https://indieauthors.social/tags/SpringerNature" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#SpringerNature</a> <a href="https://a.gup.pe/u/indieauthors" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@indieauthors</a>

Serhii NazarovetsSpringer Nature supports Ukrainian researchers during the war by providing a 100% APC waiver. Grateful for this opportunity and for making research more accessible. 👏 First time benefiting from this initiative!<a href="https://mstdn.science/tags/OpenAccess" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#OpenAccess</a> <a href="https://mstdn.science/tags/SupportUkraine" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#SupportUkraine</a> <a href="https://mstdn.science/tags/AcademicPublishing" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#AcademicPublishing</a> <a href="https://mstdn.science/tags/SpringerNature" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#SpringerNature</a>

ULB Münster › FachInfosEndspurt: Noch bis Freitag läuft eine NRW-weite Umfrage zur Qualität einiger wissenschaftlicher Verlage: <a href="https://www.ulb.uni-muenster.de/fachblog/archiv/9003" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.ulb.uni-muenster.de/fachblog/archiv/9003</a> Wir wünschen uns zahlreiche Teilnahmen, um unsere Überlegungen zu Services v.a. rund um <a href="https://openbiblio.social/tags/OpenAccess" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#OpenAccess</a> weiter verbessern zu können! <a href="https://openbiblio.social/tags/DeGruyter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#DeGruyter</a> <a href="https://openbiblio.social/tags/Elsevier" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Elsevier</a> <a href="https://openbiblio.social/tags/Frontiers" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Frontiers</a> <a href="https://openbiblio.social/tags/MDPI" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MDPI</a> <a href="https://openbiblio.social/tags/SpringerNature" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#SpringerNature</a> <a href="https://openbiblio.social/tags/TaylorFrancis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#TaylorFrancis</a> <a href="https://openbiblio.social/tags/Wiley" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Wiley</a>

Matt Hodgkinson🐘⛽🤦via <a href="https://www.facebook.com/groups/reviewer2/permalink/10161987938705469/" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.facebook.com/groups/reviewer2/permalink/10161987938705469/</a><a href="https://scicomm.xyz/tags/Mistranslations" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Mistranslations</a> <a href="https://scicomm.xyz/tags/PublicationEthics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#PublicationEthics</a> <a href="https://scicomm.xyz/tags/Retractions" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Retractions</a> <a href="https://scicomm.xyz/tags/PeerReview" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#PeerReview</a> <a href="https://scicomm.xyz/tags/ChineseTranslation" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ChineseTranslation</a> <a href="https://scicomm.xyz/tags/SpringerNature" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#SpringerNature</a>

Michael DornerWTF <a href="https://mastodon.social/tags/springernature" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#springernature</a> WTF Are we <a href="https://mastodon.social/tags/scientists" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#scientists</a> insane to keep this degenerated publishing system alive?

petersuberWould you pay to have <a href="https://fediscience.org/tags/AI" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#AI</a> summarize and promote your research? Would you pay to prevent that from happening? <a href="https://futurism.com/springer-nature-ai-media-kit" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://futurism.com/springer-nature-ai-media-kit</a>"<a href="https://fediscience.org/tags/SpringerNature" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#SpringerNature</a>…is approaching the authors of papers in its journals with AI-generated "Media Kits" to summarize and promote their research. In an email to journal authors…Springer told the scientists that its AI tool will "maximize the impact" of their research, saying the $49 package will return "high-quality" outputs for marketing and communication purposes…[But] the tool's "high-quality" outputs can't always be trusted. On an accompanying webpage linked in the email, Springer warns that "even the best AI tools make mistakes" and urges authors to painstakingly review the AI's outputs and issue corrections as needed for accuracy and clarity." <a href="https://fediscience.org/tags/ScholComm" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ScholComm</a>

petersuberNew study: "User tracking that would be unthinkable in a physical <a href="https://fediscience.org/tags/library" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#library</a> setting now happens routinely through <a href="https://fediscience.org/tags/publisher" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#publisher</a> <a href="https://fediscience.org/tags/platforms" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#platforms</a>." <a href="https://zenodo.org/records/13886473" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://zenodo.org/records/13886473</a><a href="https://fediscience.org/tags/Elsevier" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Elsevier</a> <a href="https://fediscience.org/tags/Privacy" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Privacy</a> <a href="https://fediscience.org/tags/Publishers" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Publishers</a> <a href="https://fediscience.org/tags/ScienceDirect" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ScienceDirect</a> <a href="https://fediscience.org/tags/SpringerNature" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#SpringerNature</a> <a href="https://fediscience.org/tags/SpringerLink" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#SpringerLink</a> <a href="https://fediscience.org/tags/Surveillance" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Surveillance</a>

Christoph SchindlerHeute hatten wir im Rahmen der 🚀 <a href="https://eduresearch.social/tags/openscience" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#openscience</a> Reihe von <a href="https://eduresearch.social/@dipf_aktuell" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@dipf_aktuell</a> und <a href="https://mastodon.social/@leibnizopenscience" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@leibnizopenscience</a> die spannende Panel Diskussion zu „Perspektiven für die Finanzierung der <a href="https://eduresearch.social/tags/openaccess" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#openaccess</a> -Transformation in der <a href="https://eduresearch.social/tags/eduresearch" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#eduresearch</a>“. Danke an das hochkarätige Panel mit den tollen Impulsvorträgen und für die rege Beteiligung. 👍 😀 Hier liegen die Folien des einführenden Impulsvortrags: <a href="https://osf.io/tse9u" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://osf.io/tse9u</a> Klinkhardt <a href="https://eduresearch.social/tags/SpringerNature" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#SpringerNature</a> <a href="https://fediscience.org/@GeorgKrammer" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@GeorgKrammer</a> <a href="https://eduresearch.social/@peDOCS" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@peDOCS</a> <a href="https://eduresearch.social/@FachportalPaedagogik" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@FachportalPaedagogik</a> <a href="https://eduresearch.social/tags/Erziehungswissenschaft" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Erziehungswissenschaft</a>

IGB Library<a href="https://openbiblio.social/tags/Publikationsmanagement" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Publikationsmanagement</a> in der <a href="https://openbiblio.social/tags/OnePersonLibrary" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#OnePersonLibrary</a> Informationen zum <a href="https://openbiblio.social/tags/B%C3%B6rsengang" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Börsengang</a> von <a href="https://openbiblio.social/tags/SpringerNature" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#SpringerNature</a> <a href="https://www.handelsblatt.com/finanzen/maerkte/aktien/boersengang-aktie-von-springer-nature-startet-mit-kursfeuerwerk/100075063.html" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.handelsblatt.com/finanzen/maerkte/aktien/boersengang-aktie-von-springer-nature-startet-mit-kursfeuerwerk/100075063.html</a>"So sollen die Tools etwa mit einer KI-gestützten Suche den gesamten, über 150 Jahre zusammengetragenen Wissensschatz der Verlagsgruppe analysieren können. Eine generative KI soll beim Verfassen wissenschaftlicher Publikationen helfen."Forschende & <a href="https://openbiblio.social/tags/Informationsinfrastruktur" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Informationsinfrastruktur</a> im Kontext <a href="https://openbiblio.social/tags/Datatracking" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Datatracking</a>, <a href="https://openbiblio.social/tags/predatorypublishing" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#predatorypublishing</a>, <a href="https://openbiblio.social/tags/KI" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#KI</a>, <a href="https://openbiblio.social/tags/OpenScience" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#OpenScience</a>, <a href="https://openbiblio.social/tags/Informationsethik" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Informationsethik</a>

kernpanik 🐾 🕊️ ☮<a href="https://chaos.social/tags/TIL" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#TIL</a> Der kräftig verschuldete <a href="https://chaos.social/tags/SpringerNature" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#SpringerNature</a>-Verlag, der bisher zu 47% genau jener Investmentfirma gehörte, die als <a href="https://chaos.social/tags/Heuschrecken" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Heuschrecken</a> in den deutschen Sprachgebrauch einging, und der mich zuletzt mit seinem schrottreifen Autor*innen-Frontend in den Wahnsinn trieb, ist seit dieser Woche an der Börse. Jetzt wird bestimmt alles besser!!1 🙃 <a href="https://chaos.social/tags/Neoliberalismus" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Neoliberalismus</a> <a href="https://chaos.social/tags/ScientificPublishing" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ScientificPublishing</a> <a href="https://chaos.social/tags/fail" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#fail</a>

tagesschauSpringer Nature: Warum ein Fachverlag an die Börse geht Ob "Nature" oder die "Ärztezeitung" - Springer Nature gehört mit seinen Publikationen zu den größten Wissenschaftsfachverlagen der Welt. Nun ist das Unternehmen an der Börse. Was will es dort? Von Alina Leimbach,➡️ <a href="https://www.tagesschau.de/wirtschaft/unternehmen/boersengang-springer-nature-wissenschaftsfachverlag-100.html?at_medium=mastodon&at_campaign=tagesschau.de" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.tagesschau.de/wirtschaft/unternehmen/boersengang-springer-nature-wissenschaftsfachverlag-100.html?at_medium=mastodon&at_campaign=tagesschau.de</a><a href="https://ard.social/tags/B%C3%B6rsengang" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Börsengang</a> <a href="https://ard.social/tags/SpringerNature" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#SpringerNature</a> <a href="https://ard.social/tags/Wissenschaft" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Wissenschaft</a> <a href="https://ard.social/tags/Verlage" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Verlage</a> <a href="https://ard.social/tags/Verlagsbranche" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Verlagsbranche</a>

petersuberUpdate. Here's another piece that made it through peer review (<a href="https://fediscience.org/tags/Cureus" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Cureus</a> / <a href="https://fediscience.org/tags/SpringerNature" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#SpringerNature</a>) documenting the real problems of <a href="https://fediscience.org/tags/APCs" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#APCs</a> without mentioning the existence or prevalence of non-APC OA (<a href="https://fediscience.org/tags/DiamondOA" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#DiamondOA</a>) journals. <a href="https://www.cureus.com/articles/276986-increasing-importance-and-costs-associated-with-publishing-for-dermatology-residency-applicants#!/" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.cureus.com/articles/276986-increasing-importance-and-costs-associated-with-publishing-for-dermatology-residency-applicants#!/</a>The editors and peer reviewers also allowed this howler to stand: "The <a href="https://fediscience.org/tags/GreenOA" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#GreenOA</a> option does not charge an APC and is free for authors to publish but requires a subscription to the journal to read the article." <a href="https://fediscience.org/tags/OpenAccess" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#OpenAccess</a>

Was mit Büchern»Beim für Freitag angesetzten Börsengang von <a href="https://mastodon.social/tags/SpringerNature" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#SpringerNature</a> zeichnet sich eine rege Nachfrage ab. Der Ausgabepreis der Aktien wird wohl in der oberen Hälfte der angepeilten Spanne liegen. Es könnte der zweitgrößte IPO des Jahres werden in Deutschland.«<a href="https://www.manager-magazin.de/finanzen/boerse/springer-nature-aktien-sind-begehrt-ausgabepreis-in-der-oberen-haelfte-der-spanne-a-75635196-268b-4a71-8fdc-de7862ad3d6d#ref=rss" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.manager-magazin.de/finanzen/boerse/springer-nature-aktien-sind-begehrt-ausgabepreis-in-der-oberen-haelfte-der-spanne-a-75635196-268b-4a71-8fdc-de7862ad3d6d#ref=rss</a>

jonny (good kind)springer's assets are 2/3 the ownership of publicly funded information that should have no owner, and 1/3 the 'goodwill' valuation of its oligopoly share of volunteer labor as operationalized by the value of its brands.it's a company made of nothing but the theft of the commons<a href="https://neuromatch.social/tags/SpringerNature" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#SpringerNature</a> <a href="https://neuromatch.social/tags/OpenAccess" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#OpenAccess</a> <a href="https://neuromatch.social/tags/ScholComm" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ScholComm</a>

petersuber2/ Here's the legal complaint. <a href="https://www.lieffcabraser.com/pdf/AcademicPublicationsComplaintFinal.pdf" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.lieffcabraser.com/pdf/AcademicPublicationsComplaintFinal.pdf</a>The plaintiff is Lucina Uddin (<a href="https://bird.makeup/users/lucinauddin" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@lucinauddin</a>), a professor of psychology at <a href="https://fediscience.org/tags/UCLA" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#UCLA</a>.The six publisher defendants are <a href="https://fediscience.org/tags/Elsevier" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Elsevier</a>, <a href="https://fediscience.org/tags/Sage" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Sage</a>, <a href="https://fediscience.org/tags/SpringerNature" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#SpringerNature</a>, <a href="https://fediscience.org/tags/TaylorAndFrancis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#TaylorAndFrancis</a>, <a href="https://fediscience.org/tags/Wiley" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Wiley</a>, and <a href="https://fediscience.org/tags/WoltersKluwer" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#WoltersKluwer</a>. Another defendant is the <a href="https://fediscience.org/tags/STM_Association" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#STM_Association</a>, a publisher trade organization. There are also 50 individual defendants ("John Does 1 through 50”) whose names will be revealed later.

petersuberAs early as next week <a href="https://fediscience.org/tags/SpringerNature" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#SpringerNature</a> might file the papers needed to launch a European initial public offering (<a href="https://fediscience.org/tags/IPO" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#IPO</a>) later in the fall. <a href="https://www.reuters.com/markets/europe/springer-nature-could-launch-ipo-soon-next-week-sources-say-2024-09-03/" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.reuters.com/markets/europe/springer-nature-could-launch-ipo-soon-next-week-sources-say-2024-09-03/</a> <a href="https://fediscience.org/tags/Publishers" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Publishers</a>

Egon Willigh☮gen 🟥is it me, or is <a href="https://mastodon.social/tags/SpringerNature" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#SpringerNature</a> getting sloppy with DOIs?After two months, <a href="https://doi.org/10.1038/d44148-024-00166-y" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://doi.org/10.1038/d44148-024-00166-y</a> is still not working (yes, they have been informed by CrossRef, I was told)And it looks like they forgot to update DOI links after they updated Springer References? Bc <a href="https://doi.org/10.1007/SPRINGERREFERENCE_103128" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://doi.org/10.1007/SPRINGERREFERENCE_103128</a> is not working either :(

petersuberNew study from <a href="https://fediscience.org/@stefhaustein" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@stefhaustein</a> et al. "We estimate that in 2023 <a href="https://fediscience.org/tags/MDPI" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#MDPI</a> ($681.6m), <a href="https://fediscience.org/tags/Elsevier" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Elsevier</a> ($582.8m) and <a href="https://fediscience.org/tags/SpringerNature" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#SpringerNature</a> ($546.6m) generated the most revenue with <a href="https://fediscience.org/tags/APCs" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#APCs</a>…We also show that annual spending [on APCs] almost tripled from $910.3 million in 2019 to $2.538 𝙗𝙞𝙡𝙡𝙞𝙤𝙣 in 2023 [&] that <a href="https://fediscience.org/tags/hybrid" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#hybrid</a> exceed <a href="https://fediscience.org/tags/gold" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#gold</a> fees." (Emphasis added.) <a href="https://arxiv.org/abs/2407.16551" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://arxiv.org/abs/2407.16551</a> <a href="https://fediscience.org/tags/ScholComm" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ScholComm</a>

Matt Hodgkinson"In June a notice posted on the website of the journal Nature set a new scientific record. It withdrew what is now the most highly cited research paper ever to be retracted."<a href="https://www.scientificamerican.com/article/a-retracted-stem-cell-study-reveals-sciences-shortcomings/" rel="nofollow noopener noreferrer" translate="no" target="_blank">https://www.scientificamerican.com/article/a-retracted-stem-cell-study-reveals-sciences-shortcomings/</a>HT Retraction Watch<a href="https://scicomm.xyz/tags/PublicationEthics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#PublicationEthics</a> <a href="https://scicomm.xyz/tags/NatureMagazine" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#NatureMagazine</a> <a href="https://scicomm.xyz/tags/SpringerNature" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#SpringerNature</a> <a href="https://scicomm.xyz/tags/ScientificAmerican" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ScientificAmerican</a> <a href="https://scicomm.xyz/tags/ResearchIntegrity" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#ResearchIntegrity</a> <a href="https://scicomm.xyz/tags/Retractions" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#Retractions</a> <a href="https://scicomm.xyz/tags/StemCells" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#StemCells</a> <a href="https://scicomm.xyz/tags/StemCellScience" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#StemCellScience</a> <a href="https://scicomm.xyz/tags/AdultStemCell" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#AdultStemCell</a> <a href="https://scicomm.xyz/tags/CatherineVerfaillie" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#CatherineVerfaillie</a> <a href="https://scicomm.xyz/tags/UniversityOfMinnesota" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#UniversityOfMinnesota</a> <a href="https://scicomm.xyz/tags/BoneMarrow" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#BoneMarrow</a> <a href="https://scicomm.xyz/tags/HighImpact" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#HighImpact</a> <a href="https://scicomm.xyz/tags/PeterAldhous" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#PeterAldhous</a>

Michael DornerDear <a href="https://mastodon.social/tags/springernature" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#springernature</a>! I have a question: What are actually those <a href="https://mastodon.social/tags/apc" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#apc</a> (article processing charges) my university is paying for? I am just asking for a friend who is still waiting for half a year and five revisions for proof that does not cluster fuck the content of the paper, which was already carefully drafted AND REVIEWED (!!!) following YOUR OWN <a href="https://mastodon.social/tags/TexLaTeX" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#TexLaTeX</a> template!

Frühere Suchanfragen

Suchoptionen

Verwaltet von:

Serverstatistik:

#springernature